Recent progress on triterpenoid derivatives and their anticancer potential
Phytochemistry · 2025
DOI: 10.1016/j.phytochem.2024.114257 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytochemistry, 2025. Verfasst von Zi-Xuan Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of New Drug Discovery Based on Classic Chinese Medicine Prescription, Key Laboratory of Bioactive Substances and Resources Uti…. Hauptthemen laut MEDLINE: Triterpenes. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 435 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences & Peking Union Medical College.
Abstract (Originalsprache)
Cancer poses a significant global public health challenge, with commonly used adjuvant or neoadjuvant chemotherapy often leading to adverse side effects and drug resistance. Therefore, advancing cancer treatment necessitates the ongoing development of novel anticancer agents with diverse structures and mechanisms of action. Natural products remain crucial in the process of drug discovery, serving as a primary source for pharmaceutical leads and therapeutic advancements. Triterpenoids are particularly compelling due to their complex structures and wide array of biological activities. Recent research has demonstrated that naturally occurring triterpenes and their derivatives have the potential to serve as promising candidates for new drug development. This review aims to comprehensively explore the anticancer properties of triterpenoids and their synthetic analogs, with a focus on recent advancements. Various aspects, such as synthesis, phytochemistry, and molecular simulation for structure-activity relationship analyses, are summarized. It is anticipated that triterpenoid derivatives will emerge as notable anticancer agents following further investigation into their mechanisms of action and in vivo studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of New Drug Discovery Based on Classic Chinese Medicine Prescription, Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute…
- Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province, Key Laboratory of Hunan Higher Education for Western Hunan Medicinal Plant and Ethnobotany, Hunan Provincial Higher Educati…
- Natural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, 27599, USA.
- NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Scienc…
- Antiviral Drug Discovery Laboratory, Surgical Oncology Research Facility, Duke University Medical Center, Durham, NC, 27710, USA. Electronic address: chinho.chen@duke.edu.
Förderung
- Chinese Academy of Medical Sciences & Peking Union Medical College
Zitieren
APA
Zhao, Z. X., Zou, Q. Y., Ma, Y. H., Morris-Natschke, S. L., Li, X. Y., Shi, L. C., Ma, G. X., Xu, X. D., Yang, M. H., Zhao, Z. J., Li, Y. X., Xue, J., Chen, C. H., & Wu, H. F. (2025). Recent progress on triterpenoid derivatives and their anticancer potential. Phytochemistry. https://doi.org/10.1016/j.phytochem.2024.114257
Vancouver
Zhao ZX, Zou QY, Ma YH, Morris-Natschke SL, Li XY, Shi LC, et al. Recent progress on triterpenoid derivatives and their anticancer potential. Phytochemistry. 2025. doi:10.1016/j.phytochem.2024.114257
BibTeX
@article{Zhao2025,
author = {Zhao, Zi-Xuan and Zou, Qiong-Yu and Ma, Ying-Hong and Morris-Natschke, Susan L and Li, Xiang-Yuan and Shi, Lin-Chun and Ma, Guo-Xu and Xu, Xu-Dong and Yang, Mei-Hua and Zhao, Zi-Jian and Li, Yuan-Xiang and Xue, Jing and Chen, Chin-Ho and Wu, Hai-Feng},
title = {Recent progress on triterpenoid derivatives and their anticancer potential},
journal = {Phytochemistry},
year = {2025},
doi = {10.1016/j.phytochem.2024.114257}
}
EUVIMED